The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 17890938)

Published in Am J Ther on September 24, 2007

Authors

Bill H McCarberg1, Robert L Barkin

Author Affiliations

1: Family Medicine Kaiser Permanente, Escondido, California, USA. Bill.H.Mccarberg@kp.org

Articles by these authors

Meperidine: a critical review. Am J Ther (2002) 1.58

Sublingual buprenorphine is effective in the treatment of chronic pain syndrome. Am J Ther (2005) 1.16

Efficacy of venlafaxine for the long term treatment of chronic pain with associated major depressive disorder. Am J Ther (2003) 1.06

Pharmacology of opioids in the treatment of chronic pain syndromes. Pain Physician (2011) 1.01

Topical therapy for osteoarthritis: clinical and pharmacologic perspectives. Postgrad Med (2009) 0.98

Strategies to reduce the tampering and subsequent abuse of long-acting opioids: potential risks and benefits of formulations with physical or pharmacologic deterrents to tampering. Mayo Clin Proc (2012) 0.98

A clinical and pharmacologic review of skeletal muscle relaxants for musculoskeletal conditions. Am J Ther (2005) 0.92

Urine drug test interpretation: what do physicians know? J Opioid Manag (2007) 0.90

Painful boney metastases. Am J Ther (2014) 0.86

Fibromyalgia syndrome: a discussion of the syndrome and pharmacotherapy. Am J Ther (2010) 0.86

Oxymorphone and oxymorphone extended release: a pharmacotherapeutic review. J Opioid Manag (2008) 0.85

Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician (2017) 0.84

Neuropathic pain: etiology, pathophysiology, mechanisms, and evaluations. Dis Mon (2014) 0.83

Dilemmas in chronic/persistent pain management. Am J Ther (2008) 0.82

Dilemmas in chronic/persistent pain management. Dis Mon (2010) 0.82

Options for treating postherpetic neuralgia in the medically complicated patient. Ther Clin Risk Manag (2013) 0.81

Effects of opioid prescription medication dependence and detoxification on pain perceptions and self-reports. Am J Ther (2006) 0.81

Reducing cardiovascular risks of nonsteroidal anti-inflammatory drugs by using topical formulations. Am J Cardiol (2009) 0.81

Chronic pain of osteoarthritis: considerations for selecting an extended-release opioid analgesic. Am J Ther (2008) 0.81

Tender points as predictors of distress and the pharmacologic management of fibromyalgia syndrome. Am J Ther (2003) 0.79

Reexamining the Elderly Patient's Presentation With Depression. Prim Care Companion J Clin Psychiatry (2008) 0.77

The pharmacology of topical analgesics. Postgrad Med (2013) 0.76

Fibromyalgia syndrome: a discussion of the syndrome and pharmacotherapy. Dis Mon (2011) 0.76

Nonopioid analgesics for osteoarthritis: availability of topical NSAIDs. J Pain Palliat Care Pharmacother (2010) 0.75

Treatment of Mild-to-Moderate Acute Pain. Panel discussion. Am J Ther (2009) 0.75

Proposal for a medical master class system of medical education for common complex medical entities. Am J Ther (2008) 0.75

Schizophrenia: improving the continuity of care to ensure optimal patient outcomes. Dis Mon (2012) 0.75

Resuscitation and rescue of the pharmaceutical detail: a prescriber-drug representative collaboration. Compr Ther (2009) 0.75

Management of auditory hallucinations as a sequela of traumatic brain injury: a case report and a relevant literature review. Am J Ther (2014) 0.75

Fibromyalgia. Dis Mon (2015) 0.75

Personalized pharmacotherapy for treatment approaches focused at primary insomnia. Am J Ther (2011) 0.75

The management of neuropathic pain with a focus upon older adults. Am J Ther (2012) 0.75

Topics in clinical pharmacology: renal, gastrointestinal, and pain management. Dis Mon (2010) 0.75

Tactics of the physician-controlled counter--detail and the imminent risk of not changing pharma's detail relationship with physicians. J Opioid Manag (2008) 0.75